Showing results (311-320 of 391) with videos related to

Sort By:
Pageof 40
Clinical and Experimental Rheumatology|May 24, 2014
Tocilizumab in refractory aortitis: study on 16 patients and literature reviewJavier Loricera, Ricardo Blanco, Santos Castañeda, et al.
Clinical and Experimental Rheumatology|November 15, 2022
Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patientsMónica Calderón-Goercke, Javier Loricera, Clara Moriano, et al.
Rheumatology (Oxford, England)|February 23, 2018
Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: multicentre retrospective studyBelén Atienza-Mateo, Vanesa Calvo-Río, Emma Beltrán, et al.
Clinical and Experimental Rheumatology|March 29, 2022
Vascular endothelial growth factor haplotypes are associated with severe ischaemic complications in giant cell arteritis regardless of the disease phenotypeDiana Prieto-Peña, Sara Remuzgo-Martínez, Fernanda Genre, et al.
Medicine|July 23, 2015
Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER RegistryAntonio Fernández-Nebro, Íñigo Rúa-Figueroa, Francisco J López-Longo, et al.
Frontiers in Immunology|December 19, 2019
Association of Functional Polymorphisms of KIR3DL1/DS1 With Behçet's DiseaseÁngel Castaño-Núñez, Marco-Antonio Montes-Cano, José-Raúl García-Lozano, et al.
Scientific Reports|February 28, 2019
Behçet's disease and genetic interactions between HLA-B*51 and variants in genes of autoinflammatory syndromesSergio Burillo-Sanz, Marco-Antonio Montes-Cano, José-Raúl García-Lozano, et al.
Arthritis Research & Therapy|October 14, 2015
Role of PTPN22 and CSK gene polymorphisms as predictors of susceptibility and clinical heterogeneity in patients with Henoch-Schönlein purpura (IgA vasculitis)Raquel López-Mejías, Fernanda Genre, Sara Remuzgo-Martínez, et al.
Pageof 40